Journal of Natural Products · 1996 · 94 citations · 14 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyVirologyAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyEnzyme InhibitionMedicinal PlantsNatural Product Drug DiscoveryAntiviral Natural ProductsAntiviral Structure-activity RelationshipsBioassay-guided FractionationExtractGlycoside Natural ProductsNucleoside Reverse Transcriptase Inhibitors
During the screening of natural products for their ability to inhibit the binding of HIV-REV protein to [33P]-labeled RRE RNA, one novel compound, niruriside (1), was isolated from the MeOH extract of the dried leaf of Phyllanthus niruri L. by bioassay-guided fractionation. The structure of niruriside was determined by spectroscopic methods. Niruriside showed specific inhibitory activity against the binding of REV protein to RRE RNA with an IC50 value of 3.3 microM; however, niruriside did not protect CEM-SS cells from acute HIV infection at concentrations up to 260 microM using an XTT dye reduction assay.
14
O. S. Weislow, Rebecca Kiser, Donald L. Fine et al. · JNCI Journal of the National Cancer Institute · 1989 · 691 citations
HIV-1 Reverse Transcriptase Inhibitor from <i>Phyllanthus niruri</i>
Takahiro Ogata, Hirotaka Higuchi, Shunji Mochida et al. · AIDS Research and Human Retroviruses · 1992 · 106 citations
Life Sciences, Botany, Plant Biology +16